Matthew Carpenter to Atomoxetine Hydrochloride
This is a "connection" page, showing publications Matthew Carpenter has written about Atomoxetine Hydrochloride.
Connection Strength
0.023
-
A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict. 2010 Nov-Dec; 19(6):481-9.
Score: 0.023
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.